Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Human Treg responses allow sustained recombinant adeno-associated virus–mediated transgene expression

Open access

Abstract

Recombinant adeno-associated virus (rAAV) vectors have shown promise for the treatment of several diseases; however, immune-mediated elimination of transduced cells has been suggested to limit and account for a loss of efficacy. To determine whether rAAV vector expression can persist long term, we administered rAAV vectors expressing normal, M-type α-1 antitrypsin (M-AAT) to AAT-deficient subjects at various doses by multiple i.m. injections. M-specific AAT expression was observed in all subjects in a dose-dependent manner and was sustained for more than 1 year in the absence of immune suppression. Muscle biopsies at 1 year had sustained AAT expression and a reduction of inflammatory cells compared with 3 month biopsies. Deep sequencing of the TCR Vβ region from muscle biopsies demonstrated a limited number of T cell clones that emerged at 3 months after vector administration and persisted for 1 year. In situ immunophenotyping revealed a substantial Treg population in muscle biopsy samples containing AAT-expressing myofibers. Approximately 10% of all T cells in muscle were natural Tregs, which were activated in response to AAV capsid. These results suggest that i.m. delivery of rAAV type 1-AAT (rAAV1-AAT) induces a T regulatory response that allows ongoing transgene expression and indicates that immunomodulatory treatments may not be necessary for rAAV-mediated gene therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci70314

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 171

Metadata

Authors
Mueller, C., Chulay, J. D., Trapnell, B. C., Humphries, M., Carey, B., Sandhaus, R. A., McElvaney, N. G., Messina, L., Tang, Q., Rouhani, F. N., Campbell-Thompson, M., Fu, A. D., Yachnis, A., Knop, D. R., Ye, G.-J., Brantly, M., Calcedo, R., Somanathan, S., Richman, L. P., Vonderheide, R. H., Hulme, M. A., Brusko, T. M., Wilson, J. M., & Flotte, T. R.
Affiliations
  • University of Massachusetts Chan Medical School (US)
  • Applied Genetic Technologies (United States) (US)
  • Cincinnati Children's Hospital Medical Center (US)
  • National Jewish Health (US)
  • Beaumont Hospital (IE)
  • University of Florida Health (US)
  • University of Pennsylvania (US)
Corresponding author
Flotte, Terence R.
Venue
Journal of Clinical Investigation
Published
2013-11-15
Volume
123
Issue
12
Pages
5310-5318
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2087513462
Cited by
169
References
40
Citations by year
2026: 5 · 2025: 13 · 2024: 14 · 2023: 9 · 2022: 9 · 2021: 19 · 2020: 9 · 2019: 16 · 2018: 10 · 2017: 23 · 2016: 11 · 2015: 17 · 2014: 13 · 2013: 1
FWCI
9.20
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
Funders
  • National Institutes of Health (UL1TR000161)
  • U.S. Food and Drug Administration (R01FD003896)
  • National Heart, Lung, and Blood Institute (R01HL069877, HL 69877)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
recombinant adeno-associated virus, AAV1, alpha-1 antitrypsin deficiency, regulatory T cells, natural regulatory T cells, transgene expression persistence, gene therapy, T cell receptor V beta repertoire, AAV capsid, intramuscular injection, immunomodulation, muscle fibers
MeSH terms
Dependovirus, alpha 1-Antitrypsin, Biopsy, Capsid, Clone Cells, Gene Expression Regulation, Genetic Vectors, Humans, Injections, Intramuscular, Lymphocyte Activation, Recombinant Fusion Proteins, Genetic Therapy, Gene Rearrangement, beta-Chain T-Cell Antigen Receptor, Receptors, Antigen, T-Cell, alpha-beta, Muscle, Skeletal, Transgenes, alpha 1-Antitrypsin Deficiency, T-Lymphocytes, Regulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human Treg responses allow sustained recombinant adeno-associated virus–mediated transgene expression. https://app.cochat.ai/papers/10.1172/jci70314
The paper
Mueller, C., Chulay, J. D., Trapnell, B. C., Humphries, M., Carey, B., Sandhaus, R. A., McElvaney, N. G., Messina, L., Tang, Q., Rouhani, F. N., Campbell-Thompson, M., Fu, A. D., Yachnis, A., Knop, D. R., Ye, G.-J., Brantly, M., Calcedo, R., Somanathan, S., Richman, L. P., . . . Flotte, T. R. (2013). Human Treg responses allow sustained recombinant adeno-associated virus–mediated transgene expression. Journal of Clinical Investigation. https://doi.org/10.1172/jci70314

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.